Design and synthesis of a series of meta aniline-based LFA-1 ICAM inhibitors
Guckian, K.M., Lin, E.Y., Silvian, L., Friedman, J.E., Chin, D., Scott, D.M.(2008) Bioorg Med Chem Lett 18: 5249-5251
- PubMed: 18778938 
- DOI: https://doi.org/10.1016/j.bmcl.2008.08.061
- Primary Citation of Related Structures:  
3BQM - PubMed Abstract: 
A series of meta-substituted anilines were designed and synthesized to inhibit the interaction of LFA-1 with ICAM for the treatment of autoimmune disease. Design of these molecules was performed by utilizing a co-crystal structure for structure-based drug design. The resulting molecules were found to be potent and to possess favorable pharmaceutical properties.
Organizational Affiliation: 
Biogen Idec, 14 Cambridge Center, Cambridge, MA 02142, USA. kevin.guckian@biogenidec.com